GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

Clinical trial NCT03198546 · RECRUITING

Trial details

NCT number: NCT03198546
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Immunotherapy CAR GPC3 Gene Inactivation T Cell Squamous Cell Lung Cancer

Start date: 2017-07-01
Primary completion: 2029-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.